Sweden · Delayed Price · Currency is SEK Level Bio AB Statistics
Total Valuation
Level Bio AB has a market cap or net worth of SEK 16.55 million. The enterprise value is 16.49 million.
| Market Cap | 16.55M |
| Enterprise Value | 16.49M |
Important Dates
The next estimated earnings date is Friday, February 19, 2027.
| Earnings Date | Feb 19, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
Level Bio AB has 68.40 million shares outstanding. The number of shares has decreased by -3.53% in one year.
| Current Share Class | 68.40M |
| Shares Outstanding | 68.40M |
| Shares Change (YoY) | -3.53% |
| Shares Change (QoQ) | -0.44% |
| Owned by Insiders (%) | 21.92% |
| Owned by Institutions (%) | 4.41% |
| Float | 28.13M |
Valuation Ratios
The trailing PE ratio is 3.62.
| PE Ratio | 3.62 |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 3.37 |
| EV / Sales | 0.42 |
| EV / EBITDA | 0.45 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69, with zero debt.
| Current Ratio | 0.69 |
| Quick Ratio | 0.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -48.78 |
Financial Efficiency
Return on equity (ROE) is 113.86% and return on invested capital (ROIC) is -23.03%.
| Return on Equity (ROE) | 113.86% |
| Return on Assets (ROA) | -5.84% |
| Return on Invested Capital (ROIC) | -23.03% |
| Return on Capital Employed (ROCE) | -22.86% |
| Weighted Average Cost of Capital (WACC) | 12.49% |
| Revenue Per Employee | 3.63M |
| Profits Per Employee | 457,266 |
| Employee Count | 10 |
| Asset Turnover | 2.21 |
| Inventory Turnover | 4.27 |
Taxes
In the past 12 months, Level Bio AB has paid 193,405 in taxes.
| Income Tax | 193,405 |
| Effective Tax Rate | 4.06% |
Stock Price Statistics
The stock price has decreased by -41.75% in the last 52 weeks. The beta is 1.50, so Level Bio AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -41.75% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 50.56 |
| Average Volume (20 Days) | 26,054 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Level Bio AB had revenue of SEK 36.26 million and earned 4.57 million in profits. Earnings per share was 0.07.
| Revenue | 36.26M |
| Gross Profit | 17.55M |
| Operating Income | -1.54M |
| Pretax Income | 4.77M |
| Net Income | 4.57M |
| EBITDA | 34.00M |
| EBIT | -1.54M |
| Earnings Per Share (EPS) | 0.07 |
Balance Sheet
The company has 67,000 in cash and no debt, with a net cash position of 67,000 or 0.00 per share.
| Cash & Cash Equivalents | 67,000 |
| Total Debt | n/a |
| Net Cash | 67,000 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 6.30M |
| Book Value Per Share | 0.09 |
| Working Capital | -4.01M |
Cash Flow
| Operating Cash Flow | -271,553 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 35.53M |
| Net Borrowing | 208,675 |
| Free Cash Flow | -271,553 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 48.39%, with operating and profit margins of -4.24% and 12.61%.
| Gross Margin | 48.39% |
| Operating Margin | -4.24% |
| Pretax Margin | 13.14% |
| Profit Margin | 12.61% |
| EBITDA Margin | 93.76% |
| EBIT Margin | -4.24% |
| FCF Margin | n/a |
Dividends & Yields
Level Bio AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.53% |
| Shareholder Yield | 3.53% |
| Earnings Yield | 27.62% |
| FCF Yield | -1.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |